Beneficios de la hidrocortisona agregada al tratamiento estándar de neumonías en niños de 1 a 5 años, ingresados al Hospital Vicente Corral Moscoso, Cuenca 2014-2015

Abstract

Introduction: community-acquired pneumonia remains as the most common cause of death from infection and the eighth leading cause of death in the United States. The available literature has not shown a clear benefit of the use of corticosteroids in the pneumonia. Objective: To determine the benefits of hydrocortisone venous route added to the standard treatment of pneumonias in children from 1 to 5years, admitted to the Hospital Vicente Corral Moscoso. Cuenca 2014-2015. Material and methods: we conducted a clinical trial randomized single-blind. They were divided into two treatment groups. The group of 70 children received hydrocortisone more standard treatment and group B 70 children receiving standard treatment to determine the benefits was evaluated the temperature, the respiratory rate, oxygen saturation and the days of hospitalization. Data were analyzed using student's t test and chi-square test. Differences were considered statistically significant at values of p<0.05. Results: Both groups were comparable according to sex and weight. There were no statistically significant differences in relation to temperature, although clinical differences, the frequency of children with thermal rise was lower in the group that received hydrocortisone. It became evident that the hydrocortisone improves respiration rate and oxygen saturation. The frequency of children with a normal breathing rate and saturation values of oxygen greater than 90 was greater in the group that received hydrocortisone. There were no significant differences in the observed frequency of side effects between the treatment groups. Conclusions: The hydrocortisone improves the respiratory rate, oxygen saturation and decreases hospital stay in children with pneumonia